SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

JB Chemicals & Pharmaceuticals informs about outcome of board meeting

21 May 2019 Evaluate

JB Chemicals & Pharmaceuticals has informed that it has enclosed Standalone audited financial results for the year ended on March 31, 2019 along with Auditors' Report. Consolidated audited financial results for the year ended on March 31, 2019 along with Auditors' Report. Declaration of Unmodified opinion on report issued by auditors of the Company D N V & Co., Chartered Accountants on annual Standalone audited financial statement as well as annual Consolidated audited financial statement. These financial results have been approved and taken on record by the board of directors at its meeting held today

The above information is a part of company’s filings submitted to BSE.

JB Chem & Pharma Share Price

1997.35 22.65 (1.15%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×